Extracellular superoxide dismutase polymorphism in mice

Anson Pierce, Jason Whitlark, Ladislav Dory

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective - In this study, we describe a previously unrecognized murine extracellular superoxide dismutase (ecSOD) allele and examine its distribution among various strains and its effect on the ecSOD phenotype. Methods and Results - Polymerase chain reaction analysis of genomic and cDNA from apolipoprotein E/LDLR-/- mice indicates the presence of 2 distinct transcripts for this enzyme independent of the extent of atherosclerosis or age. Sequencing and genotyping analyses reveal the presence of 2 alleles for ecSOD. One is a short variant with a 10-base pair deletion in the 3′UTR, accompanied by a single nucleotide substitution (position 61) found in the 129P3/J strain of mice. By contrast, all other strains examined carry the long form. Both free and heparin-releasable ecSOD activities in the 129P3/J strain are more than 3-fold higher than those in the C57B1/6 mice. Corresponding differences in plasma enzyme mass are observed by immunoblotting. A clear allele dose effect can be observed in F2 hybrids of these 2 strains; free and total ecSOD activities in mice homozygous for the short allele are twice those of mice homozygous for the long allele, with the heterozygote values in between. Conclusions - These data clearly demonstrate the allele-specific effects on the ecSOD phenotype independent of other strain-specific factors and underline the need for backcrossing of genetically modified mice.

Original languageEnglish (US)
Pages (from-to)1820-1825
Number of pages6
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume23
Issue number10
DOIs
StatePublished - Oct 2003
Externally publishedYes

Fingerprint

Superoxide Dismutase
Alleles
Phenotype
Inbreeding
Apolipoproteins E
Enzymes
Heterozygote
Immunoblotting
Base Pairing
Heparin
Atherosclerosis
Nucleotides
Complementary DNA
Polymerase Chain Reaction

Keywords

  • Antioxidant response
  • Apolipoprotein E/LDLR mice
  • Atherosclerosis
  • Extracellular superoxide dismutase
  • Oxidation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Extracellular superoxide dismutase polymorphism in mice. / Pierce, Anson; Whitlark, Jason; Dory, Ladislav.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 23, No. 10, 10.2003, p. 1820-1825.

Research output: Contribution to journalArticle

Pierce, Anson ; Whitlark, Jason ; Dory, Ladislav. / Extracellular superoxide dismutase polymorphism in mice. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2003 ; Vol. 23, No. 10. pp. 1820-1825.
@article{783853e5438045f0aa064bbb13c6b5df,
title = "Extracellular superoxide dismutase polymorphism in mice",
abstract = "Objective - In this study, we describe a previously unrecognized murine extracellular superoxide dismutase (ecSOD) allele and examine its distribution among various strains and its effect on the ecSOD phenotype. Methods and Results - Polymerase chain reaction analysis of genomic and cDNA from apolipoprotein E/LDLR-/- mice indicates the presence of 2 distinct transcripts for this enzyme independent of the extent of atherosclerosis or age. Sequencing and genotyping analyses reveal the presence of 2 alleles for ecSOD. One is a short variant with a 10-base pair deletion in the 3′UTR, accompanied by a single nucleotide substitution (position 61) found in the 129P3/J strain of mice. By contrast, all other strains examined carry the long form. Both free and heparin-releasable ecSOD activities in the 129P3/J strain are more than 3-fold higher than those in the C57B1/6 mice. Corresponding differences in plasma enzyme mass are observed by immunoblotting. A clear allele dose effect can be observed in F2 hybrids of these 2 strains; free and total ecSOD activities in mice homozygous for the short allele are twice those of mice homozygous for the long allele, with the heterozygote values in between. Conclusions - These data clearly demonstrate the allele-specific effects on the ecSOD phenotype independent of other strain-specific factors and underline the need for backcrossing of genetically modified mice.",
keywords = "Antioxidant response, Apolipoprotein E/LDLR mice, Atherosclerosis, Extracellular superoxide dismutase, Oxidation",
author = "Anson Pierce and Jason Whitlark and Ladislav Dory",
year = "2003",
month = "10",
doi = "10.1161/01.ATV.0000089011.51491.A6",
language = "English (US)",
volume = "23",
pages = "1820--1825",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Extracellular superoxide dismutase polymorphism in mice

AU - Pierce, Anson

AU - Whitlark, Jason

AU - Dory, Ladislav

PY - 2003/10

Y1 - 2003/10

N2 - Objective - In this study, we describe a previously unrecognized murine extracellular superoxide dismutase (ecSOD) allele and examine its distribution among various strains and its effect on the ecSOD phenotype. Methods and Results - Polymerase chain reaction analysis of genomic and cDNA from apolipoprotein E/LDLR-/- mice indicates the presence of 2 distinct transcripts for this enzyme independent of the extent of atherosclerosis or age. Sequencing and genotyping analyses reveal the presence of 2 alleles for ecSOD. One is a short variant with a 10-base pair deletion in the 3′UTR, accompanied by a single nucleotide substitution (position 61) found in the 129P3/J strain of mice. By contrast, all other strains examined carry the long form. Both free and heparin-releasable ecSOD activities in the 129P3/J strain are more than 3-fold higher than those in the C57B1/6 mice. Corresponding differences in plasma enzyme mass are observed by immunoblotting. A clear allele dose effect can be observed in F2 hybrids of these 2 strains; free and total ecSOD activities in mice homozygous for the short allele are twice those of mice homozygous for the long allele, with the heterozygote values in between. Conclusions - These data clearly demonstrate the allele-specific effects on the ecSOD phenotype independent of other strain-specific factors and underline the need for backcrossing of genetically modified mice.

AB - Objective - In this study, we describe a previously unrecognized murine extracellular superoxide dismutase (ecSOD) allele and examine its distribution among various strains and its effect on the ecSOD phenotype. Methods and Results - Polymerase chain reaction analysis of genomic and cDNA from apolipoprotein E/LDLR-/- mice indicates the presence of 2 distinct transcripts for this enzyme independent of the extent of atherosclerosis or age. Sequencing and genotyping analyses reveal the presence of 2 alleles for ecSOD. One is a short variant with a 10-base pair deletion in the 3′UTR, accompanied by a single nucleotide substitution (position 61) found in the 129P3/J strain of mice. By contrast, all other strains examined carry the long form. Both free and heparin-releasable ecSOD activities in the 129P3/J strain are more than 3-fold higher than those in the C57B1/6 mice. Corresponding differences in plasma enzyme mass are observed by immunoblotting. A clear allele dose effect can be observed in F2 hybrids of these 2 strains; free and total ecSOD activities in mice homozygous for the short allele are twice those of mice homozygous for the long allele, with the heterozygote values in between. Conclusions - These data clearly demonstrate the allele-specific effects on the ecSOD phenotype independent of other strain-specific factors and underline the need for backcrossing of genetically modified mice.

KW - Antioxidant response

KW - Apolipoprotein E/LDLR mice

KW - Atherosclerosis

KW - Extracellular superoxide dismutase

KW - Oxidation

UR - http://www.scopus.com/inward/record.url?scp=0141954207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141954207&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.0000089011.51491.A6

DO - 10.1161/01.ATV.0000089011.51491.A6

M3 - Article

VL - 23

SP - 1820

EP - 1825

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 10

ER -